The policy favors foreign investment in medical machinery to accelerate penetration in the domestic grass-roots market

Business Club December 15th With the central government’s increased financial investment in the primary health care market, the interest of foreign-funded physician-medicine delivery in the grass-roots market has also increased.

“How many billions are going to the grassroots?” On November 26th, at the press conference for the new product release of the Wuxi GE Healthcare Group B30 monitor, Zheng Pingde, vice president and general manager of GE Healthcare’s Greater China Region When the Central Government Finance Department has arranged special funds for basic medical institutions to improve their hardware and software conditions, they asked the reporter who was present. The importance of the grass-roots market for GE Healthcare is evident.

Coincidentally, the B30 monitor released by GE on the day is an economical monitor developed by the GE China R&D team for the grassroots market below the county level. In the first half of this year, GE's new Brivo 315/325 CT product designed and developed for the primary market has also been put on the market. The penetration of foreign-funded enterprises in the grass-roots market is intensifying.

Good policy

The news that Zheng Ping was excited about was that on November 18, the Ministry of Finance stated that the central government had allocated 8.8 billion yuan to fully enhance the service capabilities of primary health care institutions. 5.4 billion yuan was allocated to support the improvement of equipment conditions in county-level hospitals in the central and western regions and difficult areas in the east, training of key physicians to improve the level of primary medical care, and $2.1 billion in supporting village health clinics for information management, outpatient and overall management, and other primary health care institutions. Information platform construction; Arrange 1.1 billion yuan to support mental health system agencies to improve equipment conditions.

In addition, the National Development and Reform Commission and the Ministry of Health jointly launched a plan to improve the construction of a rural medical and health service system. Within three years, an investment of 36 billion yuan will be arranged to support the construction of 2176 county-level hospitals nationwide, so that each county has at least one county-level hospital. Basically, it has reached the level of standardization. Special funds of 31.4 billion yuan have been allocated to support the construction of 1877 county-level hospitals. In addition, funds have also been allocated to support the construction and reconstruction of township health centers and village clinics.

According to data provided by the China Medical Device Industry Association, in the monitor segment, the penetration rate of Chinese medical monitors in 2009 was only 20%, and the United States has reached 80%. According to the current high-end and economic ratio of 4:6 in the industry, the growth of China's economic medical monitors will be very large. According to Cui Wei, director of the ICU at the Second Affiliated Hospital of Zhejiang University School of Medicine, the monitor has been used in the past mainly for the monitoring of critically ill patients, and has been used to monitor the general wards and has entered the primary medical unit. Its market expansion effect very obvious.

Targeted R&D

According to Zheng Ping, the measurement technologies adopted by the monitor include the GE patented CO2 D-fend water and gas separation technology, dual-tube non-invasive blood pressure measurement technology, and SPO2 measurement technology that resists low-perfusion motion disturbances, while targeting the primary market. Features, also simplified and flexible handling of plug-in design, operation interface and menu design.

It is reported that GE's sales this year will be in the range of 800 million to 1 billion US dollars, and its goal is to triple in five years. Obviously, the grass-roots market will contribute a very important one. According to Wu Tao, President of GE Healthcare (China) Co., Ltd., taking B30 as an example, GE's target hospitals are county-level people's hospitals, Chinese medicine hospitals, and some maternity and child care hospitals. There are currently more than 2,000 counties in China, all of which are within their target range. within. This product has been on the market for one year. In addition to China, seven or eight countries that have already been listed have sold more than 800 units in the quarter. The market feedback is very good.

However, since the grass-roots market needs not only equipment but also technical talents, the service availability of the grass-roots market is more testable than the availability of products.

In response, Wu Tao said that GE has a special service model for the grassroots market. For example, the B30 monitor will first give the user a spare machine, and the pathology machine will be returned to the factory for repairs. The factory's technical strength and service quality are better than those of the local service departments. It is precisely because products are developed and manufactured in China.

In addition, the reporter also learned that GE will invest 500 million U.S. dollars in three years to strengthen R&D activities and establish six innovation centers in China. The industries covered include medical and renewable energy. The first phase candidate cities include Chengdu, Shenyang and Xi'an, these innovation centers serve the southwest, northwest, northeast, and central markets, forming synergies with GE's R&D facilities in Shanghai, Beijing, and Wuxi. At the same time, it will invest more than 1.5 billion U.S. dollars for the establishment of new joint ventures with leading domestic industries. The target areas include aviation, energy, transportation, medical and financial services.